Resources
95 Results (showing 11 - 20)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 7/14/2023 (updated 3/28/2024)
The Substance Abuse and Mental Health Services Administration (SAMHSA) has compiled a Harm Reduction Framework document that will inform the agency's activities, policies, programs, and practices. The framework document includes SAMHSA's six pillars of harm reduction as well as supporting principles and core practice areas.
Posted 5/30/2023 (updated 3/27/2024)
Overdose Detection Mapping and Application Program (ODMAP) is a free, web-based, overdose reporting platform. It is for local, state, federal, and tribal public safety and public health entities working in overdose response, reduction, and prevention.
Posted 4/14/2023 (updated 3/27/2024)
The next National Prescription Drug Take Back Day is on April 22, 2023. If you have unused or expired prescription medications, you can locate a safe and convenient disposal drop off location using the U.S Drug Enforcement Association's (DEA) website. The DEA aims to help the public remove unneeded medications from their homes as a measure of preventing medication misuse and opioid addiction from ever starting.
Posted 4/11/2023 (updated 3/27/2024)
This webinar will help set a foundation for what trauma-informed care (TIC) means and why it is important.
Posted 4/5/2023 (updated 3/27/2024)
The Northwest Prevention Technology Transfer Center (PTTC) Network has developed an Alcohol Awareness Toolkit to use during Alcohol Awareness Month. The Alcohol Awareness Toolkit will help you raise awareness about alcohol-related harms and the importance of strong alcohol policies. It also encourages engagement from prevention and public health stakeholders to strategically educate and inform decision-makers about effective alcohol policies by providing easy-to-personalize, templated opinion editorials, letters to legislators, and proclamations.
Posted 4/4/2023 (updated 3/27/2024)
The U.S. Food and Drug Administration (FDA) announced that the makers of Narcan, an opioid overdose treatment, have the agency’s approval to make the drug widely available over the counter (OTC). Narcan is the brand name of the drug naloxone, a fast-acting overdose reversal. Until now, availability varied by state – typically restricted to licensed health care providers, approved opioid overdose programs, and first responders. This is an important consideration for rural counties given that research shows that these areas are nearly three times more likely than metropolitan counties to be a low-dispensing county for naloxone.
Posted 3/21/2023 (updated 3/27/2024)
Training materials A Stimulating Talk
Posted 2/28/2023 (updated 3/27/2024)
This study's objective was to develop and validate a survey tool to assess emergency department physician attitudes, clinical practice, and willingness to perform opiate harm reduction interventions. After surveying physicians, most showed they were willing to provide necessary interventions, while few do perform them. Although there was an increased willingness to perform the interventions, a disparity remains.
Posted 2/7/2023 (updated 3/27/2024)
The National Council for Mental Wellbeing announced a toolkit, Public Safety-led Community-oriented Overdose Prevention Efforts (PS-COPE), which provides framework to use to enhance overdose prevention and response in the Black, Indigenous and people of color (BIPOC) communities. The toolkit provides tips, tools, and resources to help integrate this approach into existing overdose prevention and response efforts.
Posted 1/17/2023 (updated 3/27/2024)
The Consolidated Appropriations Act of 2023 removed the federal requirement for providers to have an X-waiver to prescribe medications for the treatment of OUD. The act amended the Controlled Substances Act. Depending on state law, practitioners who have a current DEA registration with Schedule III authority will be able to prescribe buprenorphine for OUD starting now.